Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: Role of nitric oxide and uric acid

Archives of Medical Science

Volumn 10, Issue 3, 2014, Pages 537-545

  Essawy, Soha S ^a   Abdel Sater, Khaled A ^b   Elbaz, Amani A ^c  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

^c Suez Canal University   (Egypt)

Author keywords

Fructose; Hyperuricemia; Insulin resistance; Metabolic syndrome

Indexed keywords

ALLOPURINOL; CREATININE; FRUCTOSE; GLUCOSE; INSULIN; SODIUM NITRATE; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RAT; RENOVASCULAR DISEASE; THERAPY EFFECT; TISSUE HOMOGENATE; URIC ACID URINE LEVEL;

EID: 84903635307     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2013.33222     Document Type: Article

References (50)

1. Bao Y, Shang X, Zhou L, Hu R, Li Y, Ding W. Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome. Arch Med Sci 2011; 7: 247-56.
2. Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol 2012 [Epub ahead of print].
3. De Moura RF, Ribeiro C, De Oliveira JA, De Mello MA. Metabolic syndrome signs in Wister rats submitted to different high-fructose ingestion protocols. Br J Nutr 2009; 101: 1178-84.
4. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526-32.
5. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: 625-31.
6. Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008; 88: 1733-7.
7. Gao X, Qi L, Qiao N, et al. Intake of added sugar and sugar- sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007; 50: 306-12.
8. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular reninangiotensin system. J Hypertens 2008; 26: 269-75.
9. Lin SD, Tsai DH, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 2006; 69: 512-6.
10. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008; 57: 845-52.
11. Chao HH, Liu JC, Lin J, Chen CH, Wu CH, Cheng TH. Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells. Acta Pharmacol Scin 2008; 29: 1301-12.
12. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acidin adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: 584-96.
13. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008; 300: 924-32.
14. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitritenitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7: 156-1.
15. Webb AJ, Patel N, Loukogeorgakis S, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008; 51: 784-90.
16. Jansson EA, Huang L, Malkey R, et al. A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol 2008; 4: 411-7.
17. Kapil V, Milsom AB, Okorie M, et al. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010; 56: 274-81.
18. Zharikov SI, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 2008; 295: 1183-90.
19. Sánchez-Lozada LG, Le M, Segal M, Johnson RJ. How safe is fructose for persons with or without diabetes? Am J Clin Nutr 2008; 88: 1189-90.
20. Carlström M, Larsen FJ, Nyström T, et al. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitricoxide synthase-deficient mice. Proc Natl Acad Sci U SA 2010; 107: 17716-20.
21. Hu Q, Wang C, Li J, Zhang D, Kong L. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009; 297: 1080-91.
22. Roncal CA, Reungjui S, Sánchez-Lozada LG, et al. Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Am J Nephrol 2009; 30: 399-404.
23. Vogler GA. Anesthesia and analgesia. In: The laboratory rat. Suckow MA, Weisbroth S, Franklin CL (eds). Elsevier Academic Press, New York 2006; 627-95.
24. Rudenski AS, Matthews DR, Levy JC, Turner R. Understanding insulin resistance: both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 1991; 40: 908-17.
25. Reungjui S, Roncal CA, Mu W, et al. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol 2007; 18: 2724-31.
26. Spincer K. Analytical reviews in clinical biochemistry. Ann Clin Biochem 1986; 23: 1-25.
27. Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol 1960; 13: 156-9.
28. Buccolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973; 19: 476-82.
29. Fasce CF, Vanderlinde RE. Factors affecting the results of serum cholesterol determinations: an interlaboratory evaluation. Clin Chem 1972; 118: 901-8.
30. Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 2001; 47: 1579-96.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
32. Green LC, Wagner DA, Gloowski J, Skipper DL, Wishnok JS, Tannenbaum S. Analysis of nitrite, nitrate and [15N] nitrite in biological fluids. Anal Biochem 1982; 126: 131-8.
33. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 2006; 355: 2792-3.
34. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18: 523-30.
35. Miao Z, Yan S, Wang J, et al. Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions. Inflam Res 2009; 58: 659-68.
36. Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens 2003; 21: 1563-74.
37. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-90.
38. Athyros VG, Giouleme O, Ganotakis ES, et al. Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci 2011; 7: 796-805.
39. Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 2008; 295: 1370-5.
40. Iwatani M, Wasada T, Katsumori K, Watanabe-Takahashi C, Kamatani N, Iwamoto Y. Troglitazone decreases serum uric acid concentrations in type II diabetic patients and non-diabetics. Diabetologia 2000; 43: 814-5.
41. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-42.
42. Lundberg JO, Gladwin MT, Ahluwalia A, et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 2009; 5: 865-869.
43. Ritz E. Metabolic syndrome and kidney disease. Blood Purif 2008; 26: 59-62.
44. Ruilope LM, Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep 2007; 3: 197-202.
45. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000; 71: 412-33.
46. Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism 2011; 60: 1259-70.
47. Cirillo P, Gersch MS, Mu W, et al. Ketohexokinasedependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 2009; 20: 457-9.
48. Monti LD, Barlassina C, Citterio L, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003; 52: 1270-5.
49. Fernandez ML, Ruiz R, Gonzalez MA, et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost 2004; 92: 413-8.
50. Hord NG, Tang Y, Ryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr 2009; 90: 1-10.